Prevalence of and factors associated with overweight and obesity in patients with severe mental disorders in Shenzhen: results from the urban Chinese population
Authors:
Open Access
- 7 November 2024
- journal article
- research article
- Published by Cambridge University Press (CUP) in Public Health Nutrition
- Vol. 27 (1) , e227
Abstract
Objective: To determine the prevalence of overweight and obesity in patients with severe mental disorders (SMD) and the factors associated with their socio-demographic and disease characteristics in a cross-sectional population-based study. Design: This analysis examined the prevalence of overweight and obesity in 14 868 managed SMD patients in an urban area of Shenzhen city based on data from the health information monitoring system in 2021. Multivariate logistic regression were used to identify the factors associated with the prevalence of overweight and obesity in patients with SMD. Setting: China. Participants: 14 868 patients with SMD. Results: The prevalence of overweight and obesity in patients with SMD in this study was 32·6 % and 16·1 %, respectively. In multivariate analysis, married status, Shenzhen household registration, management durations of 5–10 years and >10 years, participation in family physician services, taking clozapine or aripiprazole, FPG > 6·1 mmol/l, hypertension, TC ≥ 5·2 mmol/l, TG ≥ 1·7 mmol/l, and more frequent follow-ups in the past year were associated with higher odds of overweight and obesity. Compared to their respective reference categories, living with parents, spouse and children, taking risperidone, aripiprazole, amisulpride and perphenazine, FPG > 6·1 mmol/l, hypertension, TC ≥ 5·2 mmol/l, TG ≥ 1·7 mmol/l, and more frequent follow-ups in the past year were associated with higher odds of obesity. Conclusion: We observed a high prevalence of overweight and obesity in patients with SMD in this study. The findings highlight the need for integrated management of overweight and obesity risk factors among patients with SMD.Keywords
All Related Versions
This publication has 44 references indexed in Scilit:
- Abdominal Obesity, Adipokines and Non-communicable DiseasesThe Journal of Steroid Biochemistry and Molecular Biology, 2020
- The prevalence and independent influencing factors of obesity and underweight in patients with schizophrenia: a multicentre cross-sectional studyEating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2020
- Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controlsWorld Psychiatry, 2017
- Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendasWorld Psychiatry, 2017
- Health Care in ChinaNeurologic Clinics, 2016
- Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysisWorld Psychiatry, 2015
- Review of the evidence: prevalence of medical conditions in the United States population with serious mental illnessGeneral Hospital Psychiatry, 2015
- Obesity correlates with fewer symptoms in schizophrenia treated with long-term clozapine: Gender differencePsychiatry Research, 2015
- Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2014
- Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sampleProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2012